Alivus Life Sciences Limited — Others, 16-01-2025: Trading Window

Alivus Life Sciences Limited has announced a board meeting on January 23, 2025, to consider and approve the financial results for the quarter and half-year ended December 31, 2024. The company will also implement a trading window closure from December 31, 2024, to January 25, 2025, for designated persons in light of this upcoming announcement. This update may generate investor interest as it signals potential insights into the company’s performance, fostering a positive outlook if results meet expectations. Investors should remain aware of market sensitivity around these results and potential impacts on share price.